Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions
The novel compounds, compositions and methods disclosed herein are effective for treating a subject having or suspected of developing a health condition, for example, cancer (i.e. brain cancer or a cancer metastasizing to the brain). The method of treating cancer can include administering a pharmaceutical composition to a subject, the composition including at least one of the novel compounds disclosed herein, and optionally, one or more additional anti-cancer therapies. The compounds, compositions and methods can be further used for drug screening and other methods of detection and isolation.
1. A compound according to formula (I-D):
wherein R 5 is selected from:
and
R 6 is an aryl or a heteroaryl, wherein the aryl and the heteroaryl are each independently unsubstituted or are each independently substituted with one or more of an alkyl, alkenyl, alkynyl, alkoxyl, alkylsulfo, alkylamino, halogen, thiol, hydroxyl, nitro, cyano, cycloalkyl, heterocyclyl, heterocyclic alkyl, aryl, heteroaryl, cycloalkoxyl, heterocyclic alkoxyl, cycloalkylthio, or heterocyclic alkylthio.
2. The compound of claim 1 , wherein R 6 is one of the following:
3. A composition comprising at least one compound according to formula (I-D):
and
one or more of the following: a tag, an inactive moiety or a targeting moiety linked to the compound;
wherein R 5 is selected from:
and
R 6 is an aryl or a heteroaryl, wherein the aryl and the heteroaryl are each independently unsubstituted or are each independently substituted with one or more of an alkyl, alkenyl alkynyl, alkoxyl, alkylsulfo, alkylamino, halogen, thiol, hydroxyl, nitro, cyano, cycloalkyl, heterocyclyl, heterocyclic alkyl, aryl, heteroaryl, cycloalkoxyl, heterocyclic alkoxyl cycloalkylthio, or heterocyclic alkylthio.
4. The compound of claim 3 , wherein the tag is a fluorescent tag, radioactive tag, biotin, or any combination thereof.
5. The compound of claim 3 , wherein the inactive moiety is an ester, carbamate, aminoacyl ester, or any combination thereof.
6. The compound of claim 3 , wherein the targeting moiety is an antibody, polyethylene glycol (PEG) conjugate, or long chain polymer, peptide sequence, or any combination thereof.
7. The compound of claim 1 , wherein the compound is:
8. A composition comprising at least one compound according to claim 1 .
9. A compound according to formula II-D:
wherein J is:
wherein L is:
and
wherein K is an aryl or a heteroaryl, wherein the aryl and the heteroaryl are each independently unsubstituted or are independently substituted with one or more groups selected from alkyl, alkenyl, alkynyl, alkoxyl, alkylsulfo, alkylamino, halogen, thiol, hydroxyl, nitro, cyano, cycloalkyl, heterocyclic alkyl, aryl, heterocyclyl, heteroaryl, cycloalkoxyl, heterocyclic alkoxyl, cycloalkylthio, and heterocyclic alkylthio.
10. The compound of claim 9 , wherein K is selected from the following:
11. A composition comprising at least one compound according to claim 9 .